ZEO Scientifix Partners with Cytora and Made Scientific to Launch Allogeneic Stem Cell Therapy in U.S

Reuters

Jan 07

ZEO Scientifix Partners with Cytora and Made Scientific to Launch Allogeneic Stem Cell Therapy in U.S

ZEO Scientifix Inc. has announced a partnership with Cytora Therapeutics and Made Scientific to manufacture and commercialize Cytora’s allogeneic oral mucosal stem cell therapy in the United States. Under the collaboration, Cytora will provide manufacturing rights and continue clinical and regulatory development, Made Scientific will serve as the exclusive U.S. manufacturing partner with GMP-compliant facilities in Princeton, New Jersey, and ZEO Scientifix will act as the exclusive U.S. commercial partner, managing market access, distribution, and clinical site operations. The partnership aims to expand patient access to innovative stem cell therapies for non-healing diabetic foot ulcers and other indications, leveraging recent legislative developments in Florida and other states.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY57861) on January 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2601808543"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2601808543\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2601808543?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-07 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601808543","market":"nz","top_or_hot":-1,"title":"ZEO Scientifix Partners with Cytora and Made Scientific to Launch Allogeneic Stem Cell Therapy in U.S","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ZEO Scientifix Partners with Cytora and Made Scientific to Launch Allogeneic Stem Cell Therapy in U.S\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ZEO Scientifix Inc. has announced a partnership with Cytora <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> and Made Scientific to manufacture and commercialize Cytora’s allogeneic oral mucosal stem cell therapy in the United States. Under the collaboration, Cytora will provide manufacturing rights and continue clinical and regulatory development, Made Scientific will serve as the exclusive U.S. manufacturing partner with GMP-compliant facilities in Princeton, <a href=\"https://laohu8.com/S/NJR\">New Jersey</a>, and ZEO Scientifix will act as the exclusive U.S. commercial partner, managing market access, distribution, and clinical site operations. The partnership aims to expand patient access to innovative stem cell therapies for non-healing diabetic foot ulcers and other indications, leveraging recent legislative developments in Florida and other states.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY57861) on January 07, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZEO Scientifix Partners with Cytora and Made Scientific to Launch Allogeneic Stem Cell Therapy in U.S</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZEO Scientifix Partners with Cytora and Made Scientific to Launch Allogeneic Stem Cell Therapy in U.S\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-07 20:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ZEO Scientifix Partners with Cytora and Made Scientific to Launch Allogeneic Stem Cell Therapy in U.S\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ZEO Scientifix Inc. has announced a partnership with Cytora <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> and Made Scientific to manufacture and commercialize Cytora’s allogeneic oral mucosal stem cell therapy in the United States. Under the collaboration, Cytora will provide manufacturing rights and continue clinical and regulatory development, Made Scientific will serve as the exclusive U.S. manufacturing partner with GMP-compliant facilities in Princeton, <a href=\"https://laohu8.com/S/NJR\">New Jersey</a>, and ZEO Scientifix will act as the exclusive U.S. commercial partner, managing market access, distribution, and clinical site operations. The partnership aims to expand patient access to innovative stem cell therapies for non-healing diabetic foot ulcers and other indications, leveraging recent legislative developments in Florida and other states.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY57861) on January 07, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZEOX","symbol_name":"Zeo ScientifiX Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDLZZTdZ:1","article_id":"2601808543","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601808543","pubTimestamp":1767789032,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"ZEO Scientifix Inc. has announced a partnership with Cytora Therapeutics and Made Scientific to manufacture and commercialize Cytora’s allogeneic oral mucosal stem cell therapy in the United States. Under the collaboration, Cytora will provide manufacturing rights and continue clinical and regulatory development, Made Scientific will serve as the exclusive U.S. manufacturing partner with GMP-compliant facilities in Princeton, New Jersey, and ZEO Scientifix will act as the exclusive U.S. commercial partner, managing market access, distribution, and clinical site operations. The partnership aims to expand patient access to innovative stem cell therapies for non-healing diabetic foot ulcers and other indications, leveraging recent legislative developments in Florida and other states.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informa","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZEOX":"Zeo ScientifiX Inc.","BK4139":"生物科技"},"translate_title":"ZEO Scientifix与Cytora和Made Scientific合作在美国推出同种异体干细胞疗法","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZEOX":0.9},"content_text":"ZEO Scientifix Partners with Cytora and Made Scientific to Launch Allogeneic Stem Cell Therapy in U.S\n    \n\n        ZEO Scientifix Inc. has announced a partnership with Cytora Therapeutics and Made Scientific to manufacture and commercialize Cytora’s allogeneic oral mucosal stem cell therapy in the United States. Under the collaboration, Cytora will provide manufacturing rights and continue clinical and regulatory development, Made Scientific will serve as the exclusive U.S. manufacturing partner with GMP-compliant facilities in Princeton, New Jersey, and ZEO Scientifix will act as the exclusive U.S. commercial partner, managing market access, distribution, and clinical site operations. The partnership aims to expand patient access to innovative stem cell therapies for non-healing diabetic foot ulcers and other indications, leveraging recent legislative developments in Florida and other states.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY57861) on January 07, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}